Literature DB >> 14382501

Chlorpromazine in psychiatry.

G F VAUGHAN, D M LEIBERMAN, L C COOK.   

Abstract

Entities:  

Keywords:  CHLORPROMAZINE/therapeutic use; MENTAL DISORDERS/therapy

Mesh：

Substances：

Year:  1955        PMID： 14382501     DOI： 10.1016/s0140-6736(55)90587-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Inadequacies in the reporting of clinical drug research.

Authors:  B S GLICK
Journal:  Psychiatr Q       Date:  1963-04

2.  A retrospective controlled study of tranquillizers in long-stay patients.

Authors:  A A ROBIN
Journal:  J Neurol Neurosurg Psychiatry       Date:  1963-06       Impact factor: 10.154

3.  The effect of reserpine on the duration of manic attacks.

Authors:  D C WATT
Journal:  J Neurol Neurosurg Psychiatry       Date:  1958-11       Impact factor: 10.154

4.  Treatment of schizophrenia pacatal and chlorpromazine compared.

Authors:  J L LOMAS
Journal:  Br Med J       Date:  1957-07-13

5.  The effect of chlorpromazine on the electroencephalogram of epileptic patients.

Authors:  W FABISCH
Journal:  J Neurol Neurosurg Psychiatry       Date:  1957-08       Impact factor: 10.154

6.  A controlled clinical study of chlorpromazine and reserpine in chronic schizophrenia.

Authors:  M SHEPHERD; D C WATT
Journal:  J Neurol Neurosurg Psychiatry       Date:  1956-08       Impact factor: 10.154

7.  Biochemical mechanisms and management of choreiform movement disorders.

Authors:  L de Silva
Journal:  Drugs       Date:  1977-10       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.